Axsome Therapeutics, Inc.
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in AXSM / Axsome Therapeutics, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Axsome Therapeutics, Inc. (US:AXSM) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 1,084,536 shares of Axsome Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -1,084,536 -100.00 0 -100.00
2025-11-13 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 1,084,536 -53,212 -4.68 131,717 10.90 0.1537
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 1,137,748 161,488 16.54 118,770 4.31 0.1457
2025-08-14 2025-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 976,260 12,213 1.27 113,861 39.59 0.1413
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 976,260 12,213 113,861 0.0930
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 964,047 -31,240 -3.14 81,568 -8.81 0.0990
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 995,287 -77,955 -7.26 89,446 3.53 0.0966
2024-08-09 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 1,073,242 372,832 53.23 86,396 54.57 0.0991
2024-05-14 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 700,410 672,886 2,444.72 55,893 2,451.03 0.0634
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 27,524 6,009 27.93 2,191 45.68 0.0025
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 21,515 -24,576 -53.32 1,504 -54.59 0.0019
2023-10-27 2023-06-30 13F/A-2 AXSOME THERAPEUTICS COM 05464T104 46,091 26,187 131.57 3,312 169.71 0.0038
2023-10-12 2023-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 46,091 26,187 3,312 0.0033
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 46,091 26,187 3,312 0.0034
2023-06-01 2023-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 19,904 1,498 8.14 1,228 -13.52 0.0015
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 19,904 1,498 1,228 0.0011
2023-02-21 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 18,406 -9,301 -33.57 1,420 14.61 0.0017
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 27,707 -6,520 -19.05 1,239 -5.49 0.0015
2022-08-17 2022-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 34,227 -5,047 -12.85 1,311 -19.32 0.0015
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM 05464T104 34,227 -5,047 1,311 0.0005
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 39,274 12,975 49.34 1,625 63.48 0.0012
2022-02-11 2021-12-31 13F Axsome Therapeutics COM 05464T104 26,299 54 0.21 994 14.91 0.0008
2021-11-12 2021-09-30 13F AXSOME THERAPEUTICS COM 05464T104 26,245 1,608 6.53 865 -47.95 0.0007
2021-08-13 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 24,637 2,946 13.58 1,662 35.34 0.0014
2021-05-14 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 21,691 2,751 14.52 1,228 -20.41 0.0017
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 18,940 17,772 1,521.58 1,543 1,759.04 0.0023
2020-11-13 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 1,168 0 0.00 83 -13.54 0.0001
2020-08-11 2020-06-30 13F AXSOME THERAPEUTICS COM 05464T104 1,168 1,168 96 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.